title: Evaluation of optimal survival of primitive progenitor cells (LTC-IC) from PBPC apheresis products after overnight storage.
abstract: Optimal overnight (ON) storage of PBPC aphereses is becoming an increasingly important issue and different options for storing PBPC products exist. The survival of primitive progenitor cells is of major interest, as recent data suggest that these progenitors are not only important for long-term engraftment but also contribute significantly to the early phase of hematopoietic engraftment after myeloablative therapy. We therefore investigated the survival of primitive progenitor cells (ie long-term culture initiating cells, LTC-IC) before (ie within 2 h after finishing the apheresis procedure) and after ON storage lasting 16 to 20 h. In addition, we compared the % of recovery of LTC-IC with that of mature progenitors (ie colony-forming cells, CFC) and with the % viability of the mononuclear cells in the apheresis product. Aliquots of PBPC aphereses products were tested in collection bags at room temperature (RT), in EDTA tubes both at RT or 4 degrees C +/- the addition of autologous plasma (AP; 2.6-fold the apheresis volume) and +/- the possibility of gas exchange. Mean viable cell counts did not show strong differences between the different storage conditions and were poor predictors for the survival of CFC and LTC-IC. At RT (collection bags, EDTA tubes +/- gas exchange) recoveries (% of input) of both, CFC (18%, 18% and 31%) and LTC-IC (10%, 4%, 17%) were low. The addition of AP at RT improved the survival of CFC and LTC-IC to 66% and 38%, respectively. Optimal recoveries for both types of progenitors (CFC: 99%, LTC-IC: 109%) were obtained at 4 degrees C in the presence of AP. In addition, a good correlation between the survival of CFC and LTC-IC was obtained (r = 0.76) suggesting that the analysis of CFC may also allow some conclusions to be drawn on the survival of LTC-IC. Bone Marrow Transplantation (2000) 25, 197-200.
authors.affiliation: Department of Hematology and Oncology, University Hospital Innsbruck, Austria.
authors.forename: A L
authors.initials: AL
authors.lastname: Petzer
authors.forename: E
authors.initials: E
authors.lastname: Gunsilius
authors.forename: N
authors.initials: N
authors.lastname: Zech
authors.forename: J
authors.initials: J
authors.lastname: Clausen
authors.forename: E
authors.initials: E
authors.lastname: Hoflehner
authors.forename: W
authors.initials: W
authors.lastname: Nussbaumer
authors.forename: G
authors.initials: G
authors.lastname: Gastl
mesh_terms: D001781:Blood Component Removal / Q000379:methods*; D018929:Cell Culture Techniques; D002454:Cell Differentiation; D002470:Cell Survival; D004492:Edetic Acid; D006412:Hematopoietic Stem Cells / Q000166:cytology* / Q000378:metabolism; D006801:Humans; D010949:Plasma; D013048:Specimen Handling / Q000379:methods*; D013696:Temperature; D013997:Time Factors; D014343:Trypan Blue
chemical_list: D004492:Edetic Acid; D014343:Trypan Blue